Publicação: Evaluation of toxicity after one-months treatment with Bauhinia forficata decoction in streptozotocin-induced diabetic rats
Carregando...
Data
2004-06-08
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso aberto
Resumo
Background: Previous experiments have shown that a decoction of Bauhinia forficata leaves reduces the changes in carbohydrate and protein metabolism that occur in rats with streptozotocin-induced diabetes. In the present investigation, the serum activities of enzymes known to be reliable toxicity markers were monitored in normal and streptozotocin-diabetic rats to discover whether the use of B. forficata decoction has toxic effects on liver, muscle or pancreas tissue or on renal microcirculation. Methods: An experimental group of normal and streptozotocin-diabetic rats received an aqueous decoction of fresh B. forficata leaves (150 g/L) by mouth for 33 days while a control group of normal and diabetic rats received water for the same length of time. The serum activity of the toxicity markers lactate dehydrogenase, creatine kinase, amylase, angiotensin-converting enzyme and bilirubin were assayed before receiving B. forficata decoction and on day 19 and 33 of treatment. Results: The toxicity markers in normal and diabetic rats were not altered by the diabetes itself nor by treatment with decoction. Whether or not they received B. forficata decoction the normal rats showed a significant increase in serum amylase activity during the experimental period while there was a tendency for the diabetic rats, both treated and untreated with decoction, to have lower serum amylase activities than the normal rats. Conclusions: Administration of an aqueous decoction of B. forficata is a potential treatment for diabetes and does not produce toxic effects measurable with the enzyme markers used in our study. © 2004 Pepato et al; licensee BioMed Central Ltd.
Descrição
Palavras-chave
Amylase, Angiotensin-converting enzyme, Bauhinia forficata, Bilirubin, Creatine kinase, Extended treatment, Lactate dehydrogenase, Serum enzymes, Streptozotocin-diabetic rats, amylase, Bauhinia forticata extract, bilirubin, creatine kinase, dipeptidyl carboxypeptidase, lactate dehydrogenase, plant extract, streptozocin, unclassified drug, water, amylase blood level, animal experiment, animal model, animal tissue, aqueous solution, Bauhinia, bilirubin blood level, controlled study, creatine kinase blood level, diabetes mellitus, enzyme activity, enzyme assay, enzyme blood level, kidney circulation, lactate dehydrogenase blood level, liver toxicity, male, microcirculation, muscle disease, nephrotoxicity, nonhuman, pancreas disease, plant leaf, rat, streptozocin diabetes, animal, chemically induced disorder, experimental diabetes mellitus, metabolism, phytotherapy, toxicity testing, Wistar rat, Amylases, Animals, Creatine Kinase, Diabetes Mellitus, Experimental, L-Lactate Dehydrogenase, Male, Peptidyl-Dipeptidase A, Phytotherapy, Plant Leaves, Rats, Rats, Wistar, Streptozocin, Toxicity Tests, Chronic
Idioma
Inglês
Como citar
BMC Complementary and Alternative Medicine, v. 4.
